FDA Takes Caution on Approving New Drugs

(AP) -- Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news106639362.html">FDA Takes Caution on Approving New Drugs</a></p> <p>(AP) -- Under growing scrutiny since the blockbuster painkiller Vioxx was pulled from the market, the Food and Drug Administration in recent months has rejected a slew of experimental drugs or delayed their approval and required more data.</p>